|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
3/4/2011 8:09:15 AM
San Francisco Business Times - by Steven E.F. Brown --Genomatica Inc. raised $45 million in its fourth round of venture funding.
New investor VantagePoint Venture Partners gave the most money in the round. Other new investors included Bright Capital, part of Russia’s RU-COM Group and Waste Management Inc. (NYSE: WM).
A year ago, San Diego-based Genomatica raised $15 million from TPG Biotech, Mohr Davidow Ventures, Alloy Ventures and Draper Fisher Jurvetson. Those investors also gave money this time.
Genomatica, led by CEO Christophe Schilling, makes what it calls “greener” industrial chemicals that aren’t based on oil or other finite resources. Its first product is 1,4-butanediol, which is in pilot production. The company is making it now in 3,000 liter fermentation tanks.
BDO, as the chemical is called, is used to make spandex, automotive plastics, running shoes and other products.
Last month, Genomatica inked a deal with Houston-based Waste Management (now one of its investors) to seek ways to make industrial chemicals from synthetic gas created from municipal solid waste.
The company has raised $84 million total.
|
|
|
|
|
|
|
|
|
|
|